Reduced-frequency bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed adults with HIV: a single-centre randomised phase 2 pilot trial in Spain

Iván Chivite, Elisa Moraga, Abiu Sempere, Sònia Vicens-Artés, Pilar Callau, Cristina Rovira, Carmen Hurtado, Amedeo De Nicoló, Alejandro Sánchez-Molina, Berta Torres, Jordi Blanch, José Alcamí, José Luis Blanco, Antonio D’Avolio, Sonsoles Sánchez-Palomino, Elisa De Lazzari, Esteban Martínez

Open source

DOI: 10.1016/j.eclinm.2026.104158
Published: 2026-09
Container: eClinicalMedicine
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.eclinm.2026.104158,
  title = {Reduced-frequency bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed adults with HIV: a single-centre randomised phase 2 pilot trial in Spain},
  author = {Iván Chivite and Elisa Moraga and Abiu Sempere and Sònia Vicens-Artés and Pilar Callau and Cristina Rovira and Carmen Hurtado and Amedeo De Nicoló and Alejandro Sánchez-Molina and Berta Torres and Jordi Blanch and José Alcamí and José Luis Blanco and Antonio D’Avolio and Sonsoles Sánchez-Palomino and Elisa De Lazzari and Esteban Martínez},
  year = {2026},
  journal = {eClinicalMedicine},
  doi = {10.1016/j.eclinm.2026.104158},
  url = {https://doi.org/10.1016/j.eclinm.2026.104158}
}

RIS

TY  - JOUR
TI  - Reduced-frequency bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed adults with HIV: a single-centre randomised phase 2 pilot trial in Spain
AU  - Iván Chivite
AU  - Elisa Moraga
AU  - Abiu Sempere
AU  - Sònia Vicens-Artés
AU  - Pilar Callau
AU  - Cristina Rovira
AU  - Carmen Hurtado
AU  - Amedeo De Nicoló
AU  - Alejandro Sánchez-Molina
AU  - Berta Torres
AU  - Jordi Blanch
AU  - José Alcamí
AU  - José Luis Blanco
AU  - Antonio D’Avolio
AU  - Sonsoles Sánchez-Palomino
AU  - Elisa De Lazzari
AU  - Esteban Martínez
PY  - 2026
JO  - eClinicalMedicine
DO  - 10.1016/j.eclinm.2026.104158
UR  - https://doi.org/10.1016/j.eclinm.2026.104158
ER  -

APA

Chivite, I., Moraga, E., Sempere, A., Vicens-Artés, S., Callau, P., Rovira, C., Hurtado, C., Nicoló, A. D., Sánchez-Molina, A., Torres, B., Blanch, J., Alcamí, J., Blanco, J. L., D’Avolio, A., Sánchez-Palomino, S., Lazzari, E. D., & Martínez, E. (2026). Reduced-frequency bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed adults with HIV: a single-centre randomised phase 2 pilot trial in Spain. eClinicalMedicine. https://doi.org/10.1016/j.eclinm.2026.104158

Source records

crossref · retrieved 2026-09-25T12:15:20.696Z